Hand, Foot and Mouth Disease

Inactivated Bivalent Enterovirus Vaccine (Vero Cell) Phase I/II Clinical Trial

Phase I Clinical Trial of Enterovirus Type71 - Coxsackievirus Type A16 Bivalent Vaccine

Study on the Persistence of Immunity Following EV71 Vaccination

Hand, Foot, and Mouth Disease: Could EPs®7630 be a Treatment Option

Surveillance of HFMD in Pediatric Outpatients

Active Case Finding of Clinical Hand Foot Mouth Disease in Children Aged 6 Months Old to 18 Years Old in Indonesia

Immunogenicity of the Inactivated EV71 Vaccine Combined With Hepatitis B and Group A Meningococcal Vaccine

Lot-to-lot Consistency Study of Three Commercial Batches of Enterovirus 71 Vaccine

A Serosurvey Study of Hand, Foot, and Mouth Disease in Indonesia

A Safety Study of Inactivated EV71 Vaccine (Human Diploid Cell, KMB-17) in Chinese Adults, Children and Infants

The Immunogenicity and Safety of the Vaccination of Inactivated Enterovirus 71 Vaccine and Seasonal Influenza Vaccine

Safety Observation of Enterovirus 71 Inactivated Vaccine (Vero Cell) Combined Immunization in Shanghai

An Immunity Persistence Study of Enterovirus 71 Inactivated Vaccine (Vero Cell)

Clinical Trial of Enterovirus 71（EV71） Inactivated Vaccine in Children Aged 36-71 Months

A Follow-up Study for a Phase III, Efficacy Trial in Inactivated Enterovirus Type 71 (EV71) Vaccine

Sucralfate to Improve Oral Intake in Children With Infectious Oral Ulcers: a Randomized, Double-blind, Placebo-Controlled Trial

Immunogenicity and Safety of Two Different Commercial EV71 Vaccines

Safety and Immunogenicity of Concomitant Administration of EV71 Vaccine With EPI Vaccines

Safety and Immunogenicity of Concomitant Administration of EV71 Vaccine With Expanded Programme on Immunization Vaccines

Efficacy Trial of a Commercial EV71 Vaccine